Report ID |
138654 |
Drug Identification Number |
02236564 |
Brand name |
LOVENOX WITH PRESERVATIVE 300MG/3ML |
Common or Proper name |
Lovenox Vial |
Company Name |
SANOFI-AVENTIS CANADA INC |
Market Status |
MARKETED |
Active Ingredient(s) |
ENOXAPARIN SODIUM |
Strength(s) |
100MG |
Dosage form(s) |
SOLUTION |
Route of administration |
SUBCUTANEOUS
INTRAVENOUS
SUBCUTANEOUS
INTRAVENOUS |
Packaging size |
1 |
ATC code |
B01AB |
ATC description |
ANTITHROMBOTIC AGENTS |
Reason for shortage |
Other (Please describe in comments) |
Anticipated start date |
2021-12-30 |
Actual start date |
|
Estimated end date |
2022-01-06 |
Actual end date |
2021-12-02 |
Shortage status |
Avoided shortage |
Updated date |
2021-12-02 |
Company comments |
Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |